Article Details

TIM3 Checkpoint Is a Potential Target for Acute Myeloid Leukemia Treatment

Retrieved on: 2022-02-22 02:07:57

Tags for this article:

Click the tags to see associated articles and topics

TIM3 Checkpoint Is a Potential Target for Acute Myeloid Leukemia Treatment. View article details on hiswai:

Excerpt

In a preclinical study, the TIM3-targeted monoclonal antibody ATIK2, which induces complement-dependent cytotoxicity and antibody-dependent cellular ...

Article found on: www.targetedonc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up